Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A1,16 | Lung | Primary cancer | 3,543 | Stromal | 32.5% | 0.41 | 0.92 |
| NSCLC_38242124__IMC__87_A1,17 | Lung | Primary cancer | 2,370 | Tumor/Malignant | 42.9% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__87_A1,2 | Lung | Primary cancer | 2,918 | Stromal | 33.7% | 0.64 | 0.76 |
| NSCLC_38242124__IMC__87_A1,3 | Lung | Primary cancer | 4,326 | Tumor/Malignant | 36.7% | 0.93 | 0.18 |
| NSCLC_38242124__IMC__87_A1,4 | Lung | Primary cancer | 3,799 | Immune | 28.9% | 0.88 | 0.38 |
| NSCLC_38242124__IMC__87_A1,5 | Lung | Primary cancer | 3,344 | Tumor/Malignant | 92.4% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_A1,6 | Lung | Primary cancer | 4,178 | Tumor/Malignant | 58.8% | 0.92 | 0.21 |
| NSCLC_38242124__IMC__87_A1,7 | Lung | Primary cancer | 3,630 | Tumor/Malignant | 73.7% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__87_A1,8 | Lung | Primary cancer | 3,400 | Tumor/Malignant | 61.0% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_A1,9 | Lung | Primary cancer | 3,996 | Stromal | 30.3% | 0.89 | 0.32 |
| NSCLC_38242124__IMC__87_A2,1 | Lung | Primary cancer | 1,284 | Other | 29.5% | 0.84 | 0.44 |
| NSCLC_38242124__IMC__87_A2,10 | Lung | Primary cancer | 2,615 | Tumor/Malignant | 63.6% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_A2,11 | Lung | Primary cancer | 3,664 | Tumor/Malignant | 67.3% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__87_A2,12 | Lung | Primary cancer | 3,796 | Tumor/Malignant | 46.9% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A2,13 | Lung | Primary cancer | 2,020 | Tumor/Malignant | 34.8% | 0.86 | 0.36 |
| NSCLC_38242124__IMC__87_A2,14 | Lung | Primary cancer | 3,300 | Tumor/Malignant | 62.7% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__87_A2,15 | Lung | Primary cancer | 3,874 | Stromal | 33.5% | 0.52 | 0.78 |
| NSCLC_38242124__IMC__87_A2,16 | Lung | Primary cancer | 4,343 | Tumor/Malignant | 26.9% | 0.71 | 0.70 |
| NSCLC_38242124__IMC__87_A2,17 | Lung | Primary cancer | 2,873 | Stromal | 34.3% | 0.56 | 0.83 |
| NSCLC_38242124__IMC__87_A2,2 | Lung | Primary cancer | 2,830 | Stromal | 26.5% | 0.67 | 0.71 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A1,16 | Lung | Primary cancer | 3,543 | Stromal | 30.8% | 0.54 | 0.88 |
| NSCLC_38242124__IMC__87_A1,17 | Lung | Primary cancer | 2,370 | Tumor/Malignant | 43.2% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__87_A1,2 | Lung | Primary cancer | 2,918 | Stromal | 26.8% | 0.38 | 1.08 |
| NSCLC_38242124__IMC__87_A1,3 | Lung | Primary cancer | 4,326 | Tumor/Malignant | 36.1% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__87_A1,4 | Lung | Primary cancer | 3,799 | Lymphoid | 25.7% | 0.82 | 0.42 |
| NSCLC_38242124__IMC__87_A1,5 | Lung | Primary cancer | 3,344 | Tumor/Malignant | 87.0% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__87_A1,6 | Lung | Primary cancer | 4,178 | Tumor/Malignant | 36.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_A1,7 | Lung | Primary cancer | 3,630 | Tumor/Malignant | 71.0% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__87_A1,8 | Lung | Primary cancer | 3,400 | Tumor/Malignant | 38.4% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__87_A1,9 | Lung | Primary cancer | 3,996 | Stromal | 31.9% | 0.88 | 0.34 |
| NSCLC_38242124__IMC__87_A2,1 | Lung | Primary cancer | 1,284 | Other | 23.8% | 0.89 | 0.40 |
| NSCLC_38242124__IMC__87_A2,10 | Lung | Primary cancer | 2,615 | Tumor/Malignant | 41.9% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__87_A2,11 | Lung | Primary cancer | 3,664 | Tumor/Malignant | 67.5% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__87_A2,12 | Lung | Primary cancer | 3,796 | Tumor/Malignant | 44.9% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_A2,13 | Lung | Primary cancer | 2,020 | Tumor/Malignant | 26.1% | 0.91 | 0.22 |
| NSCLC_38242124__IMC__87_A2,14 | Lung | Primary cancer | 3,300 | Tumor/Malignant | 49.6% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__87_A2,15 | Lung | Primary cancer | 3,874 | Stromal | 25.1% | 0.87 | 0.35 |
| NSCLC_38242124__IMC__87_A2,16 | Lung | Primary cancer | 4,343 | Lymphoid | 25.1% | 0.36 | 1.08 |
| NSCLC_38242124__IMC__87_A2,17 | Lung | Primary cancer | 2,873 | Stromal | 30.3% | 0.55 | 0.95 |
| NSCLC_38242124__IMC__87_A2,2 | Lung | Primary cancer | 2,830 | Lymphoid | 24.4% | 0.83 | 0.42 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A1,16 | Lung | Primary cancer | 3,543 | Fibroblast | 34.5% | 0.65 | 0.79 |
| NSCLC_38242124__IMC__87_A1,17 | Lung | Primary cancer | 2,370 | Tumor/Malignant cell | 42.9% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__87_A1,2 | Lung | Primary cancer | 2,918 | Fibroblast | 36.3% | 0.45 | 1.07 |
| NSCLC_38242124__IMC__87_A1,3 | Lung | Primary cancer | 4,326 | Tumor/Malignant cell | 36.9% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__87_A1,4 | Lung | Primary cancer | 3,799 | Myeloid cell, unspecified | 33.0% | 0.36 | 1.02 |
| NSCLC_38242124__IMC__87_A1,5 | Lung | Primary cancer | 3,344 | Tumor/Malignant cell | 92.6% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__87_A1,6 | Lung | Primary cancer | 4,178 | Tumor/Malignant cell | 58.9% | 0.92 | 0.21 |
| NSCLC_38242124__IMC__87_A1,7 | Lung | Primary cancer | 3,630 | Tumor/Malignant cell | 58.8% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_A1,8 | Lung | Primary cancer | 3,400 | Tumor/Malignant cell | 60.6% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_A1,9 | Lung | Primary cancer | 3,996 | Fibroblast | 24.6% | 0.85 | 0.46 |
| NSCLC_38242124__IMC__87_A2,1 | Lung | Primary cancer | 1,284 | Other | 33.4% | 0.83 | 0.48 |
| NSCLC_38242124__IMC__87_A2,10 | Lung | Primary cancer | 2,615 | Tumor/Malignant cell | 62.6% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_A2,11 | Lung | Primary cancer | 3,664 | Tumor/Malignant cell | 67.4% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__87_A2,12 | Lung | Primary cancer | 3,796 | Tumor/Malignant cell | 46.0% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A2,13 | Lung | Primary cancer | 2,020 | Tumor/Malignant cell | 34.8% | 0.86 | 0.39 |
| NSCLC_38242124__IMC__87_A2,14 | Lung | Primary cancer | 3,300 | Tumor/Malignant cell | 62.7% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_A2,15 | Lung | Primary cancer | 3,874 | Fibroblast | 31.8% | 0.82 | 0.48 |
| NSCLC_38242124__IMC__87_A2,16 | Lung | Primary cancer | 4,343 | T cell | 25.4% | 0.46 | 1.03 |
| NSCLC_38242124__IMC__87_A2,17 | Lung | Primary cancer | 2,873 | Fibroblast | 29.6% | 0.68 | 0.74 |
| NSCLC_38242124__IMC__87_A2,2 | Lung | Primary cancer | 2,830 | B cell | 26.6% | 0.42 | 0.82 |